Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128522) titled 'Subretinal Injection of Amphotericin B Using a 41-gauge Needle for Refractory Candida albicans Subretinal Abscess' on July 22.
Study Type: Observational study
Study Design:
Case study
Primary Sponsor: Hangzhou First People's Hospital
Condition:
endogenous endophthalmitis,subretinal abscess
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-22
Target Sample Size: Subretinal injection group:1;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=328958
Disclaimer: Curated by HT Syndication....